Gi
Clinical Assessment Framework for Medication Administration
Pre-Administration Assessment ("What to Check Before")
Baseline Vital Signs: Measure blood pressure, heart rate, respiratory rate, temperature, and oxygen saturation before administering medications that alter hemodynamics or central nervous system function.
Laboratory Values: Review relevant lab parameters, including renal function (, serum creatinine), hepatic function (, ), electrolytes (e.g., potassium prior to loop diuretics or digoxin), and therapeutic drug levels.
Allergy and Medical History: Confirm documented allergies, specific historical reactions, current home medications to screen for interactions, and underlying organ dysfunctions.
System-Specific Physical Exam: Perform targeted baseline assessments (e.g., auscultating lung sounds prior to bronchodilators, checking baseline neurological status prior to sedatives).
Patient Presentation ("What the Patient Looks Like")
Evaluating Therapeutic Response
Observe for expected pharmacological outcomes (e.g., reduction in pain scale ratings, lowered blood pressure readings, decreased body temperature, cleared breath sounds).
Verify normalization of objective clinical markers and patient-reported symptom relief.
Recognizing Adverse Effects and Toxicity
Hypersensitivity / Anaphylaxis: Monitor for rash, urticaria, angioedema, wheezing, dyspnea, and acute hypotension.
Cardiovascular Signs: Watch for unexpected tachycardia, bradycardia, dysrhythmias, or extreme blood pressure fluctuations.
Neurological Signs: Assess for altered mental status, somnolence, agitation, confusion, ataxia, or neuromuscular irritability.
Renal and Fluid Signs: Monitor for oliguria (urine output ), peripheral edema, or unexplained weight gain.
Critical Nursing Questions ("Nursing Perspective")
Safety and Appropriateness
What is the clinical indication for this medication in this specific patient?
Is the ordered dose, route, and frequency safe based on age, weight, and renal/hepatic clearance?
Are there absolute contraindications or high-risk drug-drug interactions?
Monitoring Parameters and Hold Criteria
What are the drug's onset, peak, and duration of action?
Are baseline laboratory or vital sign thresholds met, or does the medication need to be held (e.g., hold antihypertensives if systolic blood pressure )?
Are peak and trough monitoring required for safe therapeutic dosing?
Emergency Preparedness and Patient Education
Is a specific antidote or reversal agent required to be available (e.g., naloxone, flumazenil, protamine sulfate)?
What critical signs or precautions must be emphasized during patient discharge teaching?